Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury.

Podocyte injury and loss contribute to the progression of glomerular diseases, including diabetic kidney disease. We previously found that the glomerular expression of Sirtuin-1 (SIRT1) is reduced in human diabetic glomeruli and that the podocyte-specific loss of SIRT1 aggravated albuminuria and worsened kidney disease progression in diabetic mice. SIRT1 encodes an NAD-dependent deacetylase that modifies the activity of key transcriptional regulators affected in diabetic kidneys, including NF-κB, STAT3, p53, FOXO4, and PGC1-α. However, whether the increased glomerular SIRT1 activity is sufficient to ameliorate the pathogenesis of diabetic kidney disease has not been explored. We addressed this by inducible podocyte-specific SIRT1 overexpression in diabetic OVE26 mice. The induction of SIRT1 overexpression in podocytes for six weeks in OVE26 mice with established albuminuria attenuated the progression of diabetic glomerulopathy. To further validate the therapeutic potential of increased SIRT1 activity against diabetic kidney disease, we developed a new, potent and selective SIRT1 agonist, BF175. In cultured podocytes BF175 increased SIRT1-mediated activation of PGC1-α and protected against high glucose-mediated mitochondrial injury. In vivo, administration of BF175 for six weeks in OVE26 mice resulted in a marked reduction in albuminuria and in glomerular injury in a manner similar to podocyte-specific SIRT1 overexpression. Both podocyte-specific SIRT1 overexpression and BT175 treatment attenuated diabetes-induced podocyte loss and reduced oxidative stress in glomeruli of OVE26 mice. Thus, increased SIRT1 activity protects against diabetes-induced podocyte injury and effectively mitigates the progression of diabetic kidney disease.

Hong Q ，Zhang L ，Das B ，Li Z ，Liu B ，Cai G ，Chen X ，Chuang PY ，He JC ，Lee K ... -  《-》

Reduction in podocyte SIRT1 accelerates kidney injury in aging mice.

Chuang PY ，Cai W ，Li X ，Fang L ，Xu J ，Yacoub R ，He JC ，Lee K ... -  《-》

Podocyte-specific knockin of PTEN protects kidney from hyperglycemia.

Wang H ，Feng Z ，Xie J ，Wen F ，Jv M ，Liang T ，Li J ，Wang Y ，Zuo Y ，Li S ，Li R ，Li Z ，Zhang B ，Liang X ，Liu S ，Shi W ，Wang W ... -  《-》

Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy.

Liang Y ，Liu H ，Zhu J ，Song N ，Lu Z ，Fang Y ，Teng J ，Dai Y ，Ding X ... -  《-》

Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.

Yuan Y ，Huang S ，Wang W ，Wang Y ，Zhang P ，Zhu C ，Ding G ，Liu B ，Yang T ，Zhang A ... -  《-》